THE MUTAGENIC ACTIVITY OF RAZOXANE (ICRF-159) - AN ANTICANCER AGENT

被引：5
|
作者：
ALBANESE, R
WATKINS, PA
机构：
来源：
BRITISH JOURNAL OF CANCER | 1985年 / 52卷 / 05期
关键词：
D O I：
10.1038/bjc.1985.250
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：725 / 731
页数：7
相关论文
共 50 条
  • [31] ICRF-159 (RAZOXANE) IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX - FOR THE GYNECOLOGIC ONCOLOGY GROUP
    CONROY, JF
    LEWIS, GC
    BLESSING, JA
    MANGAN, C
    HATCH, K
    WILBANKS, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (02): : 131 - 133
  • [32] EFFECT OF EXPOSURE TIME ON THE MUTAGENIC POTENCY OF THE ANTITUMOUR AGENT ICRF-159 IN L5178Y CELLS-INVITRO
    EDGAR, DH
    HEREDITY, 1984, 53 (DEC) : 556 - 556
  • [33] ICRF-159 - CURRENT STATUS AND CLINICAL PROSPECTS
    BELLET, RE
    ROZENCWEIG, M
    VONHOFF, DD
    PENTA, JS
    WASSERMAN, TH
    MUGGIA, FM
    EUROPEAN JOURNAL OF CANCER, 1977, 13 (11) : 1293 - 1298
  • [34] ICRF-159 (RAZOXANE) IN PATIENTS WITH ADVANCED NONSQUAMOUS CELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    HOMESLEY, HD
    BLESSING, JA
    BERMAN, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (04): : 325 - 326
  • [35] PHASE-II TRIAL OF RAZOXANE (ICRF-159) IN PREVIOUSLY TREATED PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA
    SHAH, MK
    CATALANO, RB
    ENGSTROM, PF
    BELLET, RE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 366 - 366
  • [36] RADIOTHERAPY COMBINED WITH ICRF-159 (NSC-129943)
    RHOMBERG, WU
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1978, 4 (1-2): : 121 - 126
  • [37] SYNERGISM OF ICRF-159 AND RADIOTHERAPY IN TREATMENT OF EXPERIMENTAL TUMORS
    HELLMANN, K
    MURKIN, GE
    CANCER, 1974, 34 (04) : 1033 - 1039
  • [38] BLOOD CLEARANCE OF ICRF-159 (NSC-129943)
    FIELD, EO
    HELLMANN, K
    MAURO, F
    CANCER CHEMOTHERAPY REPORTS PART 1, 1971, 55 (05): : 527 - &
  • [39] STUDIES OF RESISTANCE TO ICRF-159 IN CELL LINE BS-159-1
    WHITE, K
    CREIGHTON, AM
    BRITISH JOURNAL OF CANCER, 1977, 36 (03) : 421 - 421
  • [40] Analysis of a core domain in Drosophila DNA topoisomerase II -: Targeting of an antitumor agent ICRF-159
    Chang, S
    Hu, T
    Hsieh, TS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (31) : 19822 - 19828
12345